Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Once Safety Issues Are Addressed, Rx Importation "Makes Sense," President Bush Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Outstanding safety concerns are the sole reason for not yet allowing reimportation from Canada, Bush says during Q&A session with voters. By making drug imports a question of resources, he opens the door to approving some version of the practice.

You may also be interested in...



Rx Imports: President Bush Says Decision Could Come In December

Bush suggests during presidential debate that he is waiting for completion of drug importation task force’s report, due in December, before making a decision on whether to allow imports. The President says there is a possibility “you’ll hear me say, ‘I think there’s a safe way to do it.’”

Rx Imports: President Bush Says Decision Could Come In December

Bush suggests during presidential debate that he is waiting for completion of drug importation task force’s report, due in December, before making a decision on whether to allow imports. The President says there is a possibility “you’ll hear me say, ‘I think there’s a safe way to do it.’”

FDA Wants Broad Reimportation Enforcement Discretion

The agency may seek an accelerated ruling in Vermont's lawsuit against FDA in light of decisions by other states to implement importation programs. FDA Acting Commissioner Crawford tells a conference in Geneva, Switzerland that a decision on imports should be left to the agency.

Related Content

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel